Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$17.17 - $25.95 $1.03 Million - $1.56 Million
-60,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.0 - $31.78 $1.32 Million - $1.91 Million
60,000 New
60,000 $1.32 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Moon Capital Management LP Portfolio

Follow Moon Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moon Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Moon Capital Management LP with notifications on news.